Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 13/1/2021
SIETES contiene 93213 citas

 1 a 20 de 113 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Anónimo. FDA approval of cenegermin marks three firsts in drug history . DIA Daily 2018:24 de agosto. [Ref.ID 102813]
2.Enlace a cita original Cita con resumen
Lyman GH, Zon R, Harvey RD, Schilsky RL. Rationale, opportunities, and reality of biosimilar medications. N Engl J Med 2018;378:24 de mayo. [Ref.ID 102636]
3.Tiene citas relacionadas Cita con resumen
Poewe W, Seppi K. Insulin signalling: new target for Parkinson's treatments?. Lancet 2017;390:1628-30. [Ref.ID 102093]
4. Cita con resumen
Scarlett JM, Rojas JM, Matsen ME, Kaiyala KJ, Stefanovski D, Bergman RN, Nguyen HT, Dorfman MD, Lantier L, Wasserman DH, Mirzadeh Z, Unterman TG, Morton GJ, Schwartz MW. Central injection of fibroblast growth factor 1 induces sustained remission of diabetic hyperglycemia in rodents.. Nat Med 2016;22:800-6. [Ref.ID 100568]
5. Cita con resumen
Haas NB, Manola J, Uzzo RG, Flaherty KT, Wood CG, Kane C, Jewett M, Dutcher JP, Atkins MB, Pins M, Wilding G, Cella D, Wagner L, Matin S, Kuzel TM, Sexton WJ, Wong Y-N, Choueiri TK, Pili R, Puzanov I, Kohli M, Stadler W, Carducci M, Coomes R, DiPaola RS. Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial. Lancet 2016;387:2008-16. [Ref.ID 100296]
6. Cita con resumen
Anónimo. Zarxio - A filgrastim biosimilar. The Medical Letter on Drug and Therapeutics Bulletin 2016;58:34-5. [Ref.ID 100139]
7. Cita con resumen
Anónimo. Pharmaceutical giant’s plea to block rival’s filgrastim biosimilar rejected. DIA Daily 2015:20 de marzo. [Ref.ID 98863]
8.Tiene citas relacionadas Cita con resumen
Smith MEB, Totten A, Hickam DH, Fu R, Wasson N, Rahman B, Motu'apuaka M, Saha S. Pressure ulcer treatment strategies: a sytematic comparative effectiveness review. Ann Intern Med 2013;159:39-50. [Ref.ID 95856]
10.Tiene citas relacionadas Cita con resumen
Maffulli N. Autologous blood products in musculoskeletal medicine. BMJ 2013;346:9. [Ref.ID 95529]
12.Tiene citas relacionadas Cita con resumen
Helgeson MD, Lehman RA Jr, Patzkowski JC, Dmitriev AE, Rosner MK, Mack AW. Adjacent vertebral body osteolysis with bone morphogenetic protein use in transforaminal lumbar interbody fusion. The Spine Journal 2011;11:507-10. [Ref.ID 91142]
13.Tiene citas relacionadas Cita con resumen
Dmitriev AE, Lehman RA Jr, Symes AJ. Bone morphogenetic protein-2 and spinal arthrodesis: the basic science perspective on protein interaction with the nervous system. The Spine Journal 2011;11:500-5. [Ref.ID 91141]
14.Tiene citas relacionadas Cita con resumen
Howard JM, Glassman SD, Carreon LY. Posterior iliac crest pain after posterolateral fusion with or without iliac crest graft harvest. The Spine Journal 2011;11:534-7. [Ref.ID 91140]
15.Tiene citas relacionadas Cita con resumen
16.Tiene citas relacionadas Cita con resumen
Carragee EJ, Granayem AJ, Weiner BK, Rothman DJ, Bono CM. A challenge to integrity in spine publications: years of living dangerously with promotion of bone growth factors. The Spine Journal 2011;11:463-8. [Ref.ID 91138]
17. Cita con resumen
Ge ZZ, Chen HM, Gayo YJ, Liu WZ, Xu CH, Tan HH, Chen HY, Wei W, Fang JY, Xiao SD. Efficacy of thalidomide for refractory gastrointestinal bleeding from vascular malformation. Gastroenterology 2011;141:1629-37. [Ref.ID 91114]
18. Cita con resumen
Stevens AJ, Jensen JJ, Wyller K, Kilgore PC, Chatterjee S, Rohrbaugh ML. The role of public-sector research in the discovery of drugs and vaccines. N Engl J Med 2011;364:535-41. [Ref.ID 90172]
19.Tiene citas relacionadas
Deeken JF, Winer LM. Supportive treatments for oncology patients: not just icing on the cake. Ann Intern Med 2010;153:411-2. [Ref.ID 89395]
20.Tiene citas relacionadas Cita con resumen
Vadhan-Raj S, Trent J, Patel S, Zhou X, Johnson MM, Araujo D, Ludwig JA, O'Roark S, Gillenwater AM, Bueso-Ramos C, El-Naggar AK, Benjamin RS. Single-dose palifermin prevents severe oral mucositis during multicycle chemotherapy in patients with cancer. A randomized trial. Ann Intern Med 2010;153:358-67. [Ref.ID 89392]
Seleccionar todas
 1 a 20 de 113 siguiente >>